Regional microvascular function and vascular reactivity in patients with different degrees of multiple organ dysfunction syndrome

被引:31
作者
Knotzer, H
Pajk, W
Dünser, MW
Maier, S
Mayr, AJ
Ritsch, N
Friesenecker, B
Hasibeder, WR
机构
[1] Univ Innsbruck, Dept Anesthesia & Crit Care Med, A-6020 Innsbruck, Austria
[2] Krankenhaus Barmhersigen Schwestern, Dept Anesthesiol Crit Care Med, Ried, Austria
关键词
D O I
10.1213/01.ane.0000198587.10553.c1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The pathophysiology of multiple organ dysfunction syndrome (MODS) is believed to be related to that of microcirculatory dysfunction. We hypothesized that the severity of MODS is determined by measuring regional variables of microvascular function and vascular reactivity in critically ill patients. Therefore, we compared (a) reactive hyperemia response in the forearm using transcutaneous PO2/PCO2 electrodes and laser Doppler velocimetry, (b) microvascular permeability assessed by strain-gauge plethysmography in legs, and (c) variables derived from gastric tonometry in hemodynamically stable patients with moderate (n = 15) and severe (n = 15) MODS. There were no differences in systemic oxygen delivery, consumption, and oxygen extraction ratio between the groups. Mortality was 20% in patients with moderate MODS and 60% in patients with severe MODS (P = 0.025). Patients with a high MODS score had significantly larger arterial lactate concentrations (3.81 +/- 2.7 mmol/L) than patients with moderate MODS (1.66 +/- 0.82 mmol/L; P = 0.006). No significant differences in gastric pHi, gastric regional-to-arterial PCO2 difference, capillary filtration coefficient, isovolumetric venous pressure, and skin reactive hyperemia response were observed between patients with moderate and severe MODS. Once MODS is established, regional variables of microvascular function and vascular reactivity measured in this study do not reflect severity of organ dysfunction.
引用
收藏
页码:1187 / 1193
页数:7
相关论文
共 41 条
[1]  
AOKI N, 1989, AM J PHYSIOL, V256, pH1059
[2]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[3]   Association between mitochondrial dysfunction and severity and outcome of septic shock [J].
Brealey, D ;
Brand, M ;
Hargreaves, I ;
Heales, S ;
Land, J ;
Smolenski, R ;
Davies, NA ;
Cooper, CE ;
Singer, M .
LANCET, 2002, 360 (9328) :219-223
[4]   Increased microvascular water permeability in patients with septic shock, assessed with venous congestion plethysmography (VCP) [J].
Christ, F ;
Gamble, J ;
Gartside, IB ;
Kox, WJ .
INTENSIVE CARE MEDICINE, 1998, 24 (01) :18-26
[5]  
Cobb J P, 2000, Surg Infect (Larchmt), V1, P207, DOI 10.1089/109629600750018132
[6]   Microvascular blood flow is altered in patients with sepsis [J].
De Backer, D ;
Creteur, J ;
Preiser, JC ;
Dubois, MJ ;
Vincent, JL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :98-104
[7]   Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-l receptor and Fas/FasL, in sepsis [J].
De Freitas, I ;
Fernández-Somoza, M ;
Essenfeld-Sekler, E ;
Cardier, JE .
CHEST, 2004, 125 (06) :2238-2246
[8]   Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients [J].
Doig, CJ ;
Sutherland, LR ;
Sandham, JD ;
Fick, GH ;
Verhoef, M ;
Meddings, JB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :444-451
[9]   EVALUATION OF THE TRANS-CUTANEOUS OXYGEN METHOD USED AT 37-DEGREES-C FOR MEASUREMENT OF REACTIVE HYPEREMIA IN THE SKIN [J].
EWALD, U .
CLINICAL PHYSIOLOGY, 1984, 4 (05) :413-423
[10]   Impairment of skin microvascular reactivity in hypertension and uraemia [J].
Farkas, K ;
Nemcsik, J ;
Kolossváry, E ;
Járai, Z ;
Nádory, É ;
Farsang, C ;
Kiss, I .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) :1821-1827